INBIOGEN Statistics

Total Valuation

INBIOGEN has a market cap or net worth of KRW 111.03 billion. The enterprise value is 107.72 billion.

Market Cap	111.03B
Enterprise Value	107.72B

Important Dates

The next estimated earnings date is Wednesday, August 13, 2025.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

INBIOGEN has 9.98 million shares outstanding. The number of shares has increased by 9.04% in one year.

Current Share Class	9.98M
Shares Outstanding	9.98M
Shares Change (YoY)	+9.04%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.02%
Owned by Institutions (%)	0.00%
Float	2.06M

Valuation Ratios

The trailing PE ratio is 11.61.

PE Ratio	11.61
Forward PE	n/a
PS Ratio	15.19
PB Ratio	0.69
P/TBV Ratio	0.69
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.04, with an EV/FCF ratio of -60.70.

EV / Earnings	11.27
EV / Sales	14.73
EV / EBITDA	11.04
EV / EBIT	12.12
EV / FCF	-60.70

Financial Position

The company has a current ratio of 4.52, with a Debt / Equity ratio of 0.01.

Current Ratio	4.52
Quick Ratio	4.44
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.47
Interest Coverage	-104.95

Financial Efficiency

Return on equity (ROE) is 6.00% and return on invested capital (ROIC) is -2.41%.

Return on Equity (ROE)	6.00%
Return on Assets (ROA)	-2.39%
Return on Invested Capital (ROIC)	-2.41%
Return on Capital Employed (ROCE)	-3.81%
Revenue Per Employee	178.33M
Profits Per Employee	233.22M
Employee Count	41
Asset Turnover	0.05
Inventory Turnover	13.86

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	1.14
52-Week Price Change	n/a
50-Day Moving Average	10,675.80
200-Day Moving Average	n/a
Relative Strength Index (RSI)	51.10
Average Volume (20 Days)	30,037

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, INBIOGEN had revenue of KRW 7.31 billion and earned 9.56 billion in profits. Earnings per share was 957.65.

Revenue	7.31B
Gross Profit	265.60M
Operating Income	-6.18B
Pretax Income	9.56B
Net Income	9.56B
EBITDA	-5.31B
EBIT	-6.18B
Earnings Per Share (EPS)	957.65

Full Income Statement

Balance Sheet

The company has 4.15 billion in cash and 839.93 million in debt, giving a net cash position of 3.31 billion or 331.33 per share.

Cash & Cash Equivalents	4.15B
Total Debt	839.93M
Net Cash	3.31B
Net Cash Per Share	331.33
Equity (Book Value)	161.62B
Book Value Per Share	16,186.29
Working Capital	6.21B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.68 billion and capital expenditures -99.14 million, giving a free cash flow of -1.77 billion.

Operating Cash Flow	-1.68B
Capital Expenditures	-99.14M
Free Cash Flow	-1.77B
FCF Per Share	-177.73

Full Cash Flow Statement

Margins

Gross margin is 3.63%, with operating and profit margins of -84.53% and 130.78%.

Gross Margin	3.63%
Operating Margin	-84.53%
Pretax Margin	130.78%
Profit Margin	130.78%
EBITDA Margin	-72.60%
EBIT Margin	-84.53%
FCF Margin	n/a

Dividends & Yields

INBIOGEN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.04%
Shareholder Yield	n/a
Earnings Yield	8.61%
FCF Yield	-1.60%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on September 21, 2023. It was a reverse split with a ratio of 0.05.

Last Split Date	Sep 21, 2023
Split Type	Reverse
Split Ratio	0.05

Scores

INBIOGEN has an Altman Z-Score of 15.91 and a Piotroski F-Score of 2.

Altman Z-Score	15.91
Piotroski F-Score	2